Clinical trial
The Effect of Nifedipine Versus Telmisartan on Prevention of Atrial Fibrillation Recurrence in Hypertensive Patients With Paroxysmal Atrial Fibrillation by Intensive Lower Blood Pressure
NCT01435161 is registered in ClinicalTrials.gov with The Second Affiliated Hospital of Chongqing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Nifedipine Versus Telmisartan on Prevention of Atrial Fibrillation Recurrence in Hypertensive Patients With Paroxysmal Atrial Fibrillation by Intensive Lower Blood Pressure
- Lead sponsor
- The Second Affiliated Hospital of Chongqing Medical University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2007
- Completion date
- August 31, 2011
- Enrollment
- 160 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.